Lotus Eye Hospital And Institute submits board meeting intimation

Lotus Eye Hospital And Institute Ltd. | Hospital & Healthcare Services | Healthcare | BSE: 532998 | NSE: LOTUSEYE

02 Aug 2025 Evaluate

Lotus Eye Hospital And Institute has informed that Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015, the Board of Directors of the company will be meeting on Tuesday, August 12, 2025 at 04:00 PM to consider the following: 1. Un Audited Standalone Financial Results of the company for the quarter and the period ended June 30, 2025. Further, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from August 15, 2025 onwards.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Manipal Health Enter	716.15
Apollo Hospital Ent.	8850.00
Fortis Healthcare	887.30
Max Healthcare Inst.	1037.20
Narayana Hrudayalay.	1867.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.